印尼暂停并检测一批阿斯利康疫苗

dalap

印尼暂停并检测一批阿斯利康疫苗
2021年5月16日

印尼政府最近加速推动疫苗接种行动，以遏止疫情扩大。一名摩哆德士骑士日前在雅加达免下车的疫苗接种站接受注射疫苗。（路透社）
（雅加达16日讯）印尼政府周日表示，在一名22岁年轻人接种英国阿斯利康（AstraZeneca）新冠肺炎疫苗后隔天死亡，卫生部已暂停使用同一批疫苗，并对这批疫苗进行灭菌与毒性测试。

Advertisement
据路透社报导，印尼卫生部表示，这批编号为CTMAV547的AZ疫苗是在上个月运抵印尼，共有44万8480剂，并且是印尼透过世界卫生组织（WHO）主导的“新冠肺炎疫苗全球获取机制”（COVAX）预订的385万剂疫苗其中一部分。

印尼卫生部在一份声明中说，与死亡男子接种的同一批疫苗，部份已配送至首都雅加达及北苏拉威西省，还有军方。

22岁男性打疫苗后死亡

报导指，这名居住于雅加达的22岁男性在接种阿斯利康疫苗后的隔天死亡，印尼负责监督新冠肺炎疫苗异常反应的一个全国委员会已于本月初展开调查。

卫生部发言人西蒂说，这名死亡男子接种了CTMAV547批次的阿斯利康疫苗。

西蒂说：“这是政府为了确保这款疫苗的安全性，采取的谨慎做法。”不过，她接著说，其他批号的阿斯利康疫苗，配送与使用上不会受到影响。


印尼全国疫苗接种异常反应监测委员会主委亨德拉说，针对这批受影响疫苗批次的测试，至少要花上2周。

亨德拉表示：“在检测这批疫苗后，证实已灭菌并且无毒，就会恢复使用，最快取得结果的时间将会在2周之后。”


阿斯利康疫苗的公司代表并未立即回复路透社的置评要求。

自去年爆发新冠肺炎疫情大流行至今，印尼已通报约174万确诊病例，4万7967宗死亡病例。

人口约为2亿7000万人的印尼，政府最近加速推动疫苗接种行动，以遏止疫情扩大。截至周六（15日），根据官方资料，该国已有将近900万人接受完整的疫苗接种。

kingfish_w

印度生产的把印尼人送到天堂了。

brubo

All research at a Fort Detrick laboratory that handles high-level disease-causing material, such as Ebola, is on hold indefinitely after the Centers for Disease Control and Prevention found the organization failed to meet biosafety standards.

No infectious pathogens, or disease-causing material, have been found outside authorized areas at the U.S. Army Medical Research Institute of Infectious Diseases.

The CDC inspected the military research institute in June and inspectors found several areas of concern in standard operating procedures, which are in place to protect workers in biosafety level 3 and 4 laboratories, spokeswoman Caree Vander Linden confirmed in an email Friday.

The CDC sent a cease and desist order in July.

After USAMRIID received the order from the CDC, its registration with the Federal Select Agent Program, which oversees disease-causing material use and possession, was suspended. That suspension effectively halted all biological select agents and toxin research at USAMRIID, Vander Linden said in her email.

The Federal Select Agent Program does not comment on whether a program such as USAMRIID is registered and cannot comment on action taken to enforce regulations, Kathryn Harben, a spokeswoman for the CDC, wrote in an email.

“As situations warrant, [Federal Select Agent Program] will take whatever appropriate action is necessary to resolve any departures from regulatory compliance in order to help ensure the safety and security of work with select agents and toxins,” Harben said in the email.

The suspension was due to multiple causes, including failure to follow local procedures and a lack of periodic recertification training for workers in the biocontainment laboratories, according to Vander Linden. The wastewater decontamination system also failed to meet standards set by the Federal Select Agent Program, Vander Linden said in a follow-up email.

“To maximize the safety of our employees, there are multiple layers of protective equipment and validated processes,” she said.

Vander Linden could not say when the laboratory would be able to continue research.

“USAMRIID will return to fully operational status upon meeting benchmark requirements for biosafety,” she said in an email. “We will resume operations when the Army and the CDC are satisfied that USAMRIID can safely and consistently meet all standards.”

USAMRIID has been working on modified biosafety level 3 procedures and a new decontamination system since flooding in May 2018. This “increased the operational complexity of bio-containment laboratory research activities within the Institute,” she said.

At the time of the cease and desist order, USAMRIID scientists were working with agents known to cause tularemia, also called deer fly or rabbit fever, the plague and Venezuelan equine encephalitis, all of which were worked on in a biosafety level 3 laboratory. Researchers were also working with the Ebola virus in a biosafety level 4 lab, Vander Linden said.

Of the pathogens, Ebola, bacteria Yersinia pestis (plague), and bacterium Francisella tularensis (tularemia) are on the list of the Health and Human Services select agents and toxins. The three are considered Tier 1 agents, which pose a severe public health and safety threat.

Venezuelan equine encephalitis also falls under the Federal Select Agent Program, according to the Code of Federal Regulations.

The military research institute is looking at each of its contracts to see what will be affected by the shutdown. USARMIID work outside the lab is not expected to be affected, including on Ebola, Vander Linden said.

“We are coordinating closely with the CDC to ensure that critical, ongoing studies within bio-containment laboratories are completed under appropriate oversight and that research animals will continue to be cared for in accordance with all regulations,” she said in an email. “Although much of USAMRIID’s research is currently on hold, the Institute will continue its critical clinical diagnostic mission and will still be able to provide medical and subject matter expertise as needed to support the response to an infectious disease threat or other contingency.”

According to the Code of Federal Regulations, which also lists required training, records and biosafety plans, Federal Select Agents Program registration can be suspended to protect public health and safety. It is not clear if this is why the USAMRIID registration was suspended.

The code also gives the Department of Health and Human Services, under which the CDC falls, the right to inspect any site and records, without prior notifications. Vander Linden said in the email that the CDC inspected USAMRIID several times over the past year, both unannounced and on a regularly scheduled basis.

USAMRIID will work to meet requirements set by the Army and the CDC and have its suspension lifted, Vander Linden said.

“While the Institute’s research mission is critical, the safety of the workforce and community is paramount,” she said. “USAMRIID is taking the opportunity to correct deficiencies, build upon strengths, and create a stronger and safer foundation for the future.”

dalap

印尼都不敢要， 台湾当是宝。
而且还是快要过期的